HL-400

· Highlightll Pharmaceutical (USA) LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HL-400, covering 2026-04-17 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: First-in-Human Single and Multiple Dose of HL-400 [Phase 1]